Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic (inherited) condition – it is passed from parents to their children through their genes. Alpha-1 may result in serious lung disease in adults and/or liver disease at any age.
The Alpha-1 Foundation encourages testing for Alpha-1 among those at high risk for this genetic disorder. Anyone can ask their doctor to test them for Alpha-1 or they may choose to be tested confidentially.
Access to Health Coverage Means Access to Care: Patient Groups Urge Congress to Include Affordability Measures in Next Legislative Package
May 6, 2021, WASHINGTON, D.C. – 32 organizations representing millions of people with pre-existing conditions urge...
Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease
“The Arrowhead Pharmaceuticals Inc. interim study results from the open label phase 2 clinical ARO-AAT, a RNAi...
News on Plasma Awareness Act
We are excited to announce that Senators Amy Klobuchar (D-MN) and Roger Wicker (R-MS) introduced the Plasma Donation...
Accreditations
